Growth Momentum Revenue growth driven by VA prescription sales and direct-to-consumer Truvaga indicates expanding market acceptance of electroCore’s non-invasive vagus nerve stimulation. This momentum highlights a ripe opportunity to expand prescribing networks with Veterans Affairs, military healthcare facilities, and patient-focused channels.

Strategic Leadership Recent appointment of co-CEOs signals strategic leadership and potential renewed focus on scalable commercialization, partnerships, and investor communications. Align outreach to executive stakeholders about growth plans, new initiatives, and key differentiators in neuromodulation.

Brand Prestige Recognition as a top luxury biohacking and longevity brand enhances premium positioning for wellness and premium care segments. Leverage Truvaga’s luxury wellness branding to explore high-end clinics, specialty retailers, and sponsorships in health and longevity ecosystems.

Diverse Tech Stack Adoption of multi-channel tech tools (HubSpot, Marketo, NetSuite, WordPress, etc.) enables scalable marketing and CRM integration. Use to optimize targeted campaigns, account-based outreach, and efficiency in onboarding new hospital systems, clinics, and distributors.

Market Expansion Public signals of continued growth and a 2026 revenue trajectory suggest opportunity for broader hospital networks, VA facilities, and direct-to-consumer channels. Position for expansion into allied medical equipment purchasers, pain management programs, and neuromodulation adoption pilots.